Medco to Present at the Deutsche Bank 33rd Annual Health Care Conference
Novavax Opens Its First U.S. Vaccine Plant
EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product
United Therapeutics Reports First Quarter 2008 Financial Results
Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics' Heart Health Test
Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
Sidec Announces the First Protein Tomography(TM) Award at Sidec's Executive Forum at PEGS
Renovis Stockholders Approve Acquisition by Evotec
Former GE, Kodak and SGS Executive Dan Kerpelman to Join Bio-Optronics as President and CEO
United Therapeutics Announces the Results of Its 2008 Annual Meeting of Shareholders
Phosphagenics Reports Positive Pre-clinical Results for Targeted Delivery of Lidocaine
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
Alexion Reports First Quarter 2008 Results
DxTech and Nicholas Piramal in POC Diagnostics Alliance
Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
Intervet/Schering-Plough Animal Health Outlines Strength of the Combination
CureDM's Diabetes Therapy Achieves Major Development Milestone
Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets
ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2008 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.